Becoming a parent is a dream for many. But for countless couples, that dream takes time, patience, and courage. It’s a journey that can feel lonely and uncertain. Behind that journey, however, lies an industry that needs not just care and compassion but also strong leadership and clear vision to make a real difference. That’s where Mr. Vinesh Gadhia comes in.
With over three decades of experience in healthcare and a deep focus on fertility, Mr. Gadhia has been part of the industry’s evolution in India. As the CEO and Executive Director of Ferty9 Fertility Center, Mr. Gadhia’s focus lies in building strong foundations, creating access, and driving meaningful growth in one of the most emotionally sensitive and medically complex sectors. He believes in creating systems that support patients, bring teams together, and drive long-term growth.
With over three decades of experience in the Indian healthcare sector, Mr. Vinesh Gadhia’s journey in fertility has been shaped by both pharmaceutical and clinical leadership. He began as a Medical Representative at Serum Institute of India Pvt. Ltd., where he helped introduce fertility hormones like rFSH to India. He went on to lead IVF divisions at VHB Life Sciences Ltd. and Bharat Serums and Vaccines Ltd., where he was instrumental in launching India’s first biosimilar rFSH.
His move into fertility clinics began at Nova IVF Fertility, where he was a founding member and helped establish India’s first organised IVF chain. He later took charge at ART Fertility as CEO and Director and then led the world’s first Fertility Fund at BlackCap Equity Management.
With a vision to further organise and transform the fertility sector, he partnered with Verlinvest and Dr Jyothi Budi, founder of Ferty9. This led to Verlinvest acquiring a majority stake in the company and Mr. Gadhia stepping in as CEO and Executive Director. Today, he is driving Ferty9’s growth with a focus on patient-centric care, ethical practices, and advanced technology.
In his role as CEO of Ferty9, what inspires him most is the ability to change lives through fertility care. Every success story fuels his passion. He is also deeply driven by the chance to reshape industry standards, build a strong team, and break the taboos around infertility through awareness and open conversations.
Founded in December 2013, Ferty9 Fertility Center has emerged as a leading fertility chain with a strong presence across Andhra Pradesh and Telangana. With the majority stake acquired by Verlinvest, Ferty9 operates eleven strategically located centres offering a wide range of cutting-edge fertility services, including In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and more. Registered under the Assisted Reproductive Technology (Regulation) Act 2021 and The Surrogacy (Regulation) Act 2021, Ferty9 ensures top-quality care and support throughout every patient’s fertility journey.
With a team of 500+ professionals and a footprint in cities like Hyderabad, Vishakhapatnam, Vijayawada, and Warangal, the brand is driven by a clear mission: demonstrating a steadfast commitment to best-in-class results while prioritising safety, transparency, and compassionate care. Its vision is simple yet powerful—to be a trusted partner for every infertile couple on their path to parenthood.
What truly defines Ferty9 is its focus on quality, patient-centric care, integrity, accessibility, innovation, and education. From state-of-the-art embryology labs and transparent treatment plans to affordable care and continuous learning initiatives, Ferty9 is setting new benchmarks in fertility healthcare.
As Ferty9 expanded, it faced challenges in scalability, patient experience, and awareness. With growing centres, maintaining consistent quality in embryology, counselling, and operations became critical. The solution came through standardised protocols, AI-driven monitoring systems, and continuous staff training, which ensured excellence across every location.
Increased footfall brought longer wait times and bottlenecks. Ferty9 addressed this by strengthening appointment tracking, streamlining workflows, and improving real-time communication, enhancing overall patient experience. The stigma around IVF, especially in culturally rooted regions like Andhra Pradesh and Telangana, also posed a barrier. Campaigns like #TogetherInIVF, along with over 470 regional-language videos and street plays, helped normalise conversations and raise awareness.
Ferty9 stands out for its unique combination of clinical expertise, widespread accessibility, and compassionate care. Backed by 165+ years of collective experience and guided by international embryology expert Mr. Javier Herrero, the centre follows lab protocols that meet global benchmarks. Ferty9 is the only fertility brand in India offering RI Witness (error-free gamete tracking), Xiltrix (real-time lab environment monitoring), PGT (genetic testing), Class 1000 Cleanroom Labs (highest air purity standards), and K Incubators (advanced embryo culture).
It also provides initiatives like Reproductive Medicine Fellowship Program and Fertygnan Conferences to advance the field. By integrating innovation, community education, and patient-first practices, Ferty9 stands as a leader redefining fertility care in India.
At Ferty9 they understand that fertility treatments are deeply emotional experiences, not just medical ones. Through transparent communication and regional-language resources, 470+ YouTube videos and 300 blogs, it empowers patients with knowledge. Experienced counsellors offer dedicated emotional support, while initiatives like Journey to Joy foster connection among couples. Campaigns such as #TogetherInIVF and Music of Hope, a mindfulness tune, help reduce stress and normalise conversations. By addressing both emotional and clinical needs, Ferty9 creates a compassionate, supportive journey for every aspiring parent.
Ferty9 has been recognised as South India’s Best IVF Chain of 2024, expanding to 11 state-of-the-art centres while making fertility care accessible in Tier 2 and Tier 3 cities. The centre has consistently raised industry standards by offering international-quality fertility care within India, ensuring that advanced treatments are both accessible and affordable.
Its innovation-led approach has resulted in a notable rise in success rates, supported by cutting-edge infrastructure and advanced embryology labs. A major milestone has been the launch of Project Lakshya: Integrated Digital Ecosystem—a first-of-its-kind solution that integrates EMR, CRM, ERP, BI, RI Witness System, Embryology Lab Monitoring, Customer Feedback, Supply Chain, and HR systems. This digital shift has improved clinical outcomes, real-time monitoring, and patient care.
“At Ferty9, every recognition we receive is a reflection of our unwavering commitment to patient-centric care,” says Gadhia.
The centre’s award for Excellence in Patient Experience reaffirms its dedication to compassionate, ethical, and technology-driven fertility treatment. These recognitions not only validate their efforts but also motivate the team to continuously raise the bar in fertility care, innovate patient engagement strategies, and ensure that every couple who walks through their doors feels heard, supported, and empowered on their journey to parenthood.
Follow us on Google News